Wednesday, January 18, 2017

Alcobra Stock Down on Poor Late-Stage Data on ADHD Drug - Yahoo Finance


Investopedia

Alcobra Stock Down on Poor Late-Stage Data on ADHD Drug
Yahoo Finance
Shares of Alcobra Ltd. ADHD declined 50.7% after the company reported disappointing top-line results from a phase III study, MEASURE, on experimental candidate metadoxine, extended release (MDX) for the treatment of ADHD in adult patients.
Alcobra Tanks 50% on Failed ADHD Study (ADHD)Investopedia
Alcobra Shares Plummet as ADHD Drug FailsTheStreet.com
Alcobra to stop testing sole drug for ADHD after study failsReuters
CNA Finance (press release) -StreetInsider.com -Investorplace.com
all 62 news articles »

Alcobra Ltd. (NASDAQ:ADHD) has industry P/E ratio of 45.9 - The Newburgh Press


Alcobra Ltd. (NASDAQ:ADHD) has industry P/E ratio of 45.9
The Newburgh Press
Alcobra Ltd. (NASDAQ:ADHD) reported sales (ttm) of 0, whereas, 2 number of analysts estimated the mean sale of 0 million. The analysts estimated sales for the higher end at 0 million and lower end at 0 million while the year ago reported sale was 0 ...

and more »

Malfunctioning part of 'ADHD gene' identified, clearing way for specialized medications - Genetic Literacy Project


Genetic Literacy Project

Malfunctioning part of 'ADHD gene' identified, clearing way for specialized medications
Genetic Literacy Project
ADHD is highly genetic, and [the ADGRL3 gene] in particular has long been implicated it its development…Now, a new study goes even further, finding a specific malfunction on the gene that is highly associated with [attention deficit hyperactivity ...

and more »

Malfunctioning part of 'ADHD gene' identified, clearing way for specialized medications - Genetic Literacy Project


Genetic Literacy Project

Malfunctioning part of 'ADHD gene' identified, clearing way for specialized medications
Genetic Literacy Project
ADHD is highly genetic, and [the ADGRL3 gene] in particular has long been implicated it its development…Now, a new study goes even further, finding a specific malfunction on the gene that is highly associated with [attention deficit hyperactivity ...

and more »

Many youth with ADHD given antipsychotic drugs: study - rdnewsnow.com


Globalnews.ca

Many youth with ADHD given antipsychotic drugs: study
rdnewsnow.com
TORONTO — An Ontario study shows one in 20 children and youth have attention deficit hyperactivity disorder and many are prescribed antipsychotic drugs, despite having no other mental health diagnosis. Attention deficit hyperactivity disorder, or ADHD ...
Too many children with ADHD are taking anti-psychotic drugs: Canadian studyGlobalnews.ca

all 56 news articles »

Shire Announces Seventh Annual Scholarship for Individuals With ADHD - Justmeans


Shire Announces Seventh Annual Scholarship for Individuals With ADHD
Justmeans
LEXINGTON, MA, January 18, 2017 /3BL Media/ – Shire plc (LSE: SHP, NASDAQ: SHPG) is pleased to announce the launch of the 2017 Michael Yasick ADHD Scholarship. The scholarship program is for legal residents of the United States who are under the ...

Too many children with ADHD are taking anti-psychotic drugs: Canadian study - Globalnews.ca


Globalnews.ca

Too many children with ADHD are taking anti-psychotic drugs: Canadian study
Globalnews.ca
ADHD is diagnosed in about one in 20 kids, according to new Canadian research, but how many are prescribed anti-psychotics that come with lifelong side effects? Scientists behind a new study out of the Institute for Clinical Evaluative Sciences (ICES ...